OBJECTIVE: This study used gated myocardial perfusion imaging (G-MPI) to assess the clinical value of Xinmailong injection in chronic @entity712 ( @entity712 ). METHODS: A total of 102 @entity712 @entity1 were randomly divided into the control group (n = 51) and the Xinmailong group (n = 51). @entity1 in the control group were routinely treated. @entity1 in the Xinmailong group were additionally treated with Xinmailong injection in addition to routine treatment. Before and 3 months after treatment, G-MPI was used to determine changes in the left ventricular ejection fraction (LVEF), left ventricular end-diastolic volume (LVEDV) and left ventricular end-systolic volume (LVESV). Fourteen days after treatment, changes in plasma @entity3876 ( @entity3876 ) levels were determined. RESULTS: Before treatment, there were no significant differences in LVEF, LVEDV, LVESV, and @entity3876 levels between the two groups (all P > 0.05). After treatment, LVEDV, LVESV, and @entity3876 levels were significantly lower, and LVEF was significantly higher in the Xinmailong group than in the control group (all P < 0.05). CONCLUSION: Additional use of Xinmailong injection in addition to routine treatment improves cardiac function of @entity712 @entity1 . Because of the safety and effectiveness of Xinmailong injection; this therapy should be promoted.

Use of gated myocardial perfusion imaging to assess clinical value of xinmailong injection in chronic XXXX .

@entity1 :: ('9606', 'Species') :: ['Patients', 'patients'] @entity712 :: ('MESH:D006333', 'Disease') :: ['congestive heart failure', 'CHF'] @entity3876 :: ('4879', 'Gene') :: ['BNP', 'brain natriuretic peptide']
@entity712 :: (MESH:D006333,Disease) :: ['congestive heart failure']
